Dr. Brooks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1838 Greene Tree Rd
Ste 535
Baltimore, MD 21208Phone+1 410-653-3923Fax+1 410-653-1296
Education & Training
- UPMC Medical EducationFellowship, Cardiovascular Disease, 1999 - 2002
- UPMC Medical EducationResidency, Internal Medicine, 1996 - 1999
- University of Pittsburgh School of MedicineClass of 1996
Certifications & Licensure
- MD State Medical License 2003 - 2026
- PA State Medical License 1997 - 2008
- SC State Medical License 2003 - 2003
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 145 citations2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.Karen A Hicks, Kenneth W Mahaffey, Roxana Mehran, Steven E Nissen, Stephen D Wiviott
Journal of the American College of Cardiology. 2018-03-06 - 166 citations2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.Karen A Hicks, Kenneth W Mahaffey, Roxana Mehran, Steven E Nissen, Stephen D Wiviott
Circulation. 2018-02-27 - 1 citationsFDA perspective on the need for revised performance goals for evaluating stenting of femoropopliteal arteries.Lindsay K. Pack, Donna C. Buckley, Jennifer L. Goode, Steven S. Brooks, Lisa M. Lim
Catheterization and Cardiovascular Interventions. 2014-05-01
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
- Dr. Steven Brooks, Former FDA Medical Officer, Peripheral Vascular Device Branch, Office of Device Evaluation, Joins NDA PartnersJanuary 5th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: